Biotech · Public company · Foster City, CA, US
Sagimet Biosciences Inc.
Ticker SGMT · SEC CIK 0001400118
Track this companyFree. Adds Sagimet Biosciences Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials104 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline11
- DenifanstatPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- TVB-2640Phase 2 · Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TVB-2640 25 mg (US)Phase 2 · MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)ClinicalTrials.gov · fetched Nov 12, 2026
- TVB-2640 50 mg (China)Phase 2 · MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)ClinicalTrials.gov · fetched Nov 12, 2026
- TVB-2640 50 mg (US)Phase 2 · MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)ClinicalTrials.gov · fetched Nov 12, 2026
- TVB-2640 75 mg (US)Phase 2 · MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)ClinicalTrials.gov · fetched Nov 12, 2026
- [14C]-TVB-2640Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- DenifanstatPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- ResmetiromPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TVB-2640 - 50 mgPhase 1 · Non-alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- TVB-3567Phase 1 · AcneClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)PHASE3 · RECRUITING · started Oct 21, 2026ClinicalTrials.gov NCT07863193 · fetched Nov 12, 2026
- A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Sep 30, 2025ClinicalTrials.gov NCT07216313 · fetched Nov 12, 2026
- Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without AcnePHASE1 · RECRUITING · started Jun 3, 2025ClinicalTrials.gov NCT06989840 · fetched Nov 12, 2026
- Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 20, 2023ClinicalTrials.gov NCT05743621 · fetched Nov 12, 2026
- A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionPHASE1 · COMPLETED · started May 1, 2023ClinicalTrials.gov NCT05835180 · fetched Nov 12, 2026
- Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male SubjectsPHASE1 · COMPLETED · started Nov 21, 2022ClinicalTrials.gov NCT05657834 · fetched Nov 12, 2026
- Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)PHASE2 · COMPLETED · started Aug 12, 2021ClinicalTrials.gov NCT04906421 · fetched Nov 12, 2026
- Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung CarcinomasPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 11, 2019ClinicalTrials.gov NCT03808558 · fetched Nov 12, 2026
- Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)PHASE2 · COMPLETED · started Mar 22, 2019ClinicalTrials.gov NCT03938246 · fetched Nov 12, 2026
- Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic SyndromePHASE1_PHASE2 · COMPLETED · started Feb 1, 2017ClinicalTrials.gov NCT02948569 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 21, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 3, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026